The first federal bellwether jury trial against Johnson & Johnson (J&J) subsidiary, DePuy, for its allegedly defective Pinnacle Hip Implant, is underway in Dallas, Texas, with jury selection and opening arguments completed
The U.S....
The first federal bellwether jury trial against Johnson & Johnson (J&J) subsidiary, DePuy, for its allegedly defective Pinnacle Hip Implant, is underway in Dallas, Texas, with jury selection and opening arguments completed
The U.S....
The U.S. Food and Drug Administration (FDA) issued DePuy’s Synthes device with a Class I label, its most serious warning, after the company reported 15 injuries associated with its jaw implant.
A Johnson & Johnson subsidiary, DePuy, has...
A $2.5 billion DePuy ASR settlement has been finalized for the thousands of patients who were forced to undergo painful revision surgery to replace their metal hip implants.
The maker of the defective implants, DePuy, as well as its parent...